These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9163558)

  • 1. Effects of 5-HT1A receptor ligands in a modified Geller-Seifter conflict model in the rat.
    King CM; Gommans J; Joordens RJ; Hijzen TH; Maes RA; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):121-8. PubMed ID: 9163558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The modified Geller-Seifter test in rats was insensitive to GABAB receptor positive modulation or blockade, or 5-HT1A receptor activation.
    Paterson NE; Hanania T
    Behav Brain Res; 2010 Mar; 208(1):258-64. PubMed ID: 20006648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of light cycle on response to 5-HT1A ligands in punished responding in rats.
    Gleason SD; Leander JD
    Behav Pharmacol; 1999 Dec; 10(8):785-91. PubMed ID: 10780294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of 5-HT(1A) receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model.
    Cervo L; Mocaër E; Bertaglia A; Samanin R
    Neuropharmacology; 2000 Apr; 39(6):1037-43. PubMed ID: 10727714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys.
    Winsauer PJ; Moerschbaecher JM
    Behav Pharmacol; 2000 Nov; 11(7-8):535-53. PubMed ID: 11198126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
    Jackson DM; Wallsten CE; Jerning E; Hu PS; Deveney AM
    Psychopharmacology (Berl); 1998 Oct; 139(4):300-10. PubMed ID: 9809851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of 5-HT1A receptor ligands by drug discrimination.
    Wolff MC; Leander JD
    Eur J Pharmacol; 1997 Aug; 333(2-3):113-22. PubMed ID: 9314023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia.
    Bardin L; Tarayre JP; Koek W; Colpaert FC
    Eur J Pharmacol; 2001 Jun; 421(2):109-14. PubMed ID: 11399266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 8-OH-DPAT and WAY-100635 on performance on a time-constrained progressive-ratio schedule.
    Ho MY; Body S; Kheramin S; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2003 May; 167(2):137-44. PubMed ID: 12655461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties of the 5-HT1A receptor agonist BAY x 3702 in the rat.
    De Vry J; Jentzsch KR
    Eur J Pharmacol; 1998 Sep; 357(1):1-8. PubMed ID: 9788767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT1A receptor full and partial agonists and 5-HT2C (but not 5-HT3) receptor antagonists increase rates of punished responding in rats.
    Cervo L; Samanin R
    Pharmacol Biochem Behav; 1995 Dec; 52(4):671-6. PubMed ID: 8587903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
    Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus properties of flesinoxan: effects of enantiomers, (S)-UH301 and WAY-100635.
    Gommans J; Hijzen TH; Maes RA; Mos J; Olivier B
    Eur J Pharmacol; 1995 Sep; 284(1-2):135-40. PubMed ID: 8549617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats.
    Sánchez C; Mørk A
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):287-94. PubMed ID: 10422888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB; Koek W
    Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW; Ogilvie J; Houghton AK
    Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5-HT
    Fletcher PJ; Zeeb FD; Browne CJ; Higgins GA; Soko AD
    Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.